The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response will purchase two antitoxin drugs for inhalational anthrax to add to the Strategic National Stockpile. “By expanding the treatment options available within the SNS, we can help meet the diverse needs of the American people in an anthrax-related emergency,” said Robin Robinson, director of ASPR’s Biomedical Advanced Research and Development Authority.